23Jan
Blog: Cooley's 2019 Life Sciences M&A Year in Review
2019 was a banner year for billion-dollar life sciences M&A transactions. A wave of big-ticket transactions by global pharmaceutical companies drove life sciences M&A activity to its fourth-largest year on record in 2019, with aggregate deal value in...
By:
Cooley LLP
Related
Prior to the new year, the National Labor Relations Board (NLRB or Board) made several big moves, ap...
Read More >
Seyfarth Synopsis: CBD is “thriving” in the current regulatory environment, but is it doing so il...
Read More >
With the pace of orthopedic medical practice recapitalizations showing no signs of slowing, it is ap...
Read More >
On July 11, 2019, the Italian Government adopted Law Decree No. 64/2019 (DL 64/2019) which amends th...
Read More >
Oh, wait. According to a recent study, women pay 20 percent more than men in bank fees and penaltie...
Read More >
On September 24, 2019 the U.S. Department of Labor (DOL) issued a revised Final Overtime Rule increa...
Read More >